Opendata, web and dolomites

METAdiag

METAdiag: Diagnose to Cure

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 METAdiag project word cloud

Explore the words cloud of the METAdiag project. It provides you a very rough idea of what is the project "METAdiag" about.

hallmark    abnormal    feed    metadiag    diet    fact    time    quantifying    receive    correctly    milestones    inborn    conduct    status    proprietary    market    metabolic    damages    debilitating    overlooked    symptoms    platform    accuracy    surface    poorer    stay    overfeeding    consumption    lifelong    function    perspectives    detect    22    subjects    burden    healthy    clinical    patients    damage    longer    mechanism    therapies    42    progress    starting    million    entail    conversely    impairments    nutrient    serious    errors    starving    boost    balanced    economic    cells    quality    first    energetics    prevent    organisms    small    generate    influencing    monitor    initially    commercial    levels    tests    as    proving    prognosis    energetic    network    metafora    onset    people    revenues    diagnosis    incur    hire    life    earlier    adapt    expecting    diabetes    despite    appear    cancer    turn    clinicians    reliability    company    positioned    impaired    impacts    invasive    reverted    metabolism    financial    living    uniquely    diagnostic    feasibility    detection    transporters    diseases    treatments    cell   

Project "METAdiag" data sheet

The following table provides information about the project.

Coordinator
METAFORA BIOSYSTEMS 

Organization address
address: 29 RUE DU FAUBOURG SAINT JACQUES
city: PARIS
postcode: 75014
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country France [FR]
 Project website http://www.metafora-biosystems.com
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3.1.3. (Treating and managing disease)
 Code Call H2020-SMEINST-1-2016-2017
 Funding Scheme SME-1
 Starting year 2017
 Duration (year-month-day) from 2017-02-01   to  2017-05-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    METAFORA BIOSYSTEMS FR (PARIS) coordinator 50˙000.00

Map

 Project objective

As all living organisms, our cells need to feed on a balanced diet to stay healthy and correctly function. To do that, cells adapt their nutrient consumption according to their energetic needs. If the uptake mechanism is impaired, it impacts cell metabolism. Both starving cells & overfeeding cells are a hallmark for the onset and progress of serious diseases like diabetes, cancer or inborn errors of metabolism, which can all be seen as metabolic diseases. These are debilitating conditions that need lifelong treatments, entail poorer life quality and incur a major economic burden. Subjects appear initially healthy and symptoms are often overlooked, but by the time of diagnosis, damage can no longer be reverted. Conversely, early detection could prevent most of the damages by starting specific therapies. However, despite the fact that all metabolic diseases have abnormal cell energetics, there are no tests for cell metabolism in clinical practice. In response, we at METAFORA aim to bring to market METAdiag, the first diagnostic platform able to assess and monitor the metabolic status of our cells. This unique and non-invasive diagnostic system is able to detect abnormal cell energetics by quantifying the levels of nutrient transporters at the cell surface. After proving the reliability and accuracy of our platform at a small scale, we now aim to take a step further towards the market. Thus, in Phase 1 we aim to conduct a Feasibility Study that will help us to assess and achieve the significant milestones influencing the project from the technical, commercial and financial perspectives. Based on proprietary technology and on a strong collaboration network, METAdiag will be uniquely positioned to detect metabolic impairments, allowing clinicians to achieve an earlier diagnosis and patients to receive better management and prognosis. In turn, METAdiag will boost the growth of our company, expecting to generate €42 million in revenues and to hire 22 new people in 5 years.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "METADIAG" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "METADIAG" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.3.)

GACD (2019)

Global Alliance for Chronic Diseases Secretariat

Read More  

ISLET (2020)

Advancing Innovative Stem Cell-based Therapy for Diabetes in Europe

Read More  

INTE-AFRICA (2019)

Integrating and decentralising diabetes and hypertension services in Africa

Read More